Renal Progenitor Cell Purification via Surface Marker Sorting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing renal progenitor cells (RPCs) from pluripotent stem cells (PSCs) lack efficiency in achieving high-purity populations, which is crucial for regenerative medicine applications, particularly for renal diseases like renal failure.
Innovation Solution
A method involving the use of specific cell surface markers such as CD9-negative, CD55-negative, CD106-positive, CD140a-positive, CD140b-positive, CD165-positive, and CD271-positive markers to sort and purify RPC populations from PSCs, allowing for the induction and differentiation of high-purity RPCs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional differentiation methods are used to produce RPCs from PSCs, then the production process is simple, but the purity of RPC population is insufficient
Solution Approach 1:
The patent extracts and isolates specific cell surface markers (CD9, CD55, CD106, CD140a, CD140b, CD165, CD271, CD326) that are selectively expressed on RPCs from the complex mixture of differentiated cells. By identifying and targeting these specific markers, the method extracts the RPC population from the heterogeneous cell population, achieving high purity through marker-based selection rather than complex multi-step differentiation protocols.
Solution Approach 2:
The patent introduces cell surface markers as intermediary substances that mediate between the differentiated cell population and the desired RPC population. These markers serve as identifiable intermediaries that allow selective binding and isolation of RPCs using flow cytometry or magnetic sorting techniques, simplifying the separation process while achieving high purity without requiring complex differentiation control mechanisms.
2Manufacturing precision
If multiple cell surface markers are used for sorting, then the purity of RPC population increases, but the complexity of the sorting process increases
Solution Approach 1:
The patent segments the sorting process into discrete marker-based selection steps, where each cell surface marker (CD9, CD55, CD106, CD140a, CD140b, CD165, CD271, CD326) represents a separate selectable characteristic. By segmenting the population based on individual marker expression patterns, the method achieves high purity through systematic separation rather than requiring complex simultaneous manipulation of multiple markers.
Solution Approach 2:
The patent transitions from a single-dimension differentiation approach to a multi-dimensional marker-based sorting approach. Instead of relying on a single differentiation protocol parameter, the method utilizes multiple cell surface markers as separate sorting dimensions, allowing independent selection based on each marker's expression pattern. This dimensional expansion enables precise purification while maintaining operational simplicity through standardized flow cytometry or magnetic sorting techniques for each marker.
Data Source
AI summary
A method for acquiring and producing high-purity renal progenitor cells from a renal progenitor cell population into which pluripotent stem cells are induced to differentiate, by identifying a cell surface antigen marker specific to renal progenitor cells. The high-purity renal progenitor cells can be used in regenerative medicine for renal diseases, such as renal failure.